Abstract:Gastrointestinal (GI) ulcers are essentially internal wounds that resist normal healing processes. Since their pathogenesis is poorly understood, and the etiologic (e.g., gastric acid, aspirin-like drugs, stress) and aggravating factors (e.g., H. pylori) are not well characterized, the remaining therapeutic option is to accelerate healing. Superficial mucosal lesions, i.e., erosions usually heal by epithelial regeneration and restitution, but when ulcers involve the muscularis propria, smooth muscle cells do not divide/regenerate. These deep lesions are filled by granulation tissue, i.e., angiogenesis followed by proliferation of connective tissue fibroblasts that deposit collagen over which adjacent surviving and dividing epithelial cells migrate to complete the healing. Our laboratory was the first to postulate that stimulation of angiogenesis alone might be sufficient to accelerate ulcer healing in the GI tract. Indeed, daily treatment of rats with bFGF, PDGF or VEGF markedly improved the healing of cysteamine-induced chronic duodenal ulcers, without any reduction in gastric acid secretion. These results were reproduced by a single dose of gene therapy by adenoviral vectors encoding PDGF or VEGF genes. The molar potency of angiogenic growth factors was 2-7 million times better than the antiulcerogenic effect of antisecretory H2 antagonists. Since histologically & pathologically gastroduodenal ulcers look similar to ulcers in the lower GI tract, we also predicted that the healing of experimental ulcerative colitis might be also improved by these angiogenic growth factors. Rectal enemas containing bFGF or PDGF indeed accelerated the healing of chemically induced ulcerative colitis in rats. VEGF, also known as VPF (vascular permeability factor), however, had no effect or slightly aggravated the colonic lesions. Injection of anti-VEGF neutralizing antibodies, however, counteracted the increased vascular permeability in the early stages of experimental ulcerative colitis and subsequently decreased the number of inflammatory cells in colonic ulcers in rats, resulting in significantly improved healing in the lower GI tract lesions. Thus, the three angiogenic growth factors tested exerted beneficial effect on gastroduodenal ulcers, and rectal enemas with bFGF or PDGF also accelerated the healing of experimental ulcerative colitis. Surprisingly, we achieved the latter effect with anti-VEGF antibodies, most likely because of the pro-inflammatory actions of VEGF in the pathogenesis of ulcerative colitis.

Pharmacotherapy for Gastrointestinal Angiodysplasia: is it effective?

Recent advances in the treatment of refractory gastrointestinal angiodysplasia

Von Willebrand Disease and Angiodysplasia: a wider view of pathogenesis in pursuit of therapy

Successful management of ileocecal angiodysplasia with an overt bleeding with supra selective transcatheter embolization-case report

Endoscopic therapy for gastrointestinal angiodysplasia

S982 Efficacy and Safety of Hormonal Therapy in the Treatment of Bleeding From Gastrointestinal Vascular Malformations: A Systematic Review and Meta-analysis

Efficacy and safety of thalidomide in gastrointestinal angiodysplasias: systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

S1026 Efficacy and Safety of Somatostatin Analogue in Chronic Bleeding From Gastrointestinal Angiodysplasia: A Systematic Review and Meta-Analysis

Safety and efficacy of thalidomide in treatment of gastrointestinal bleeding secondary to angioectasias: a systematic review and meta-analysis

Therapeutic Strategy for Gastrointestinal Bleeding in Patients With Left Ventricular Assist Device

Thalidomide for Recurrent Small Intestinal Gastrointestinal Bleeding

Epidemiology and risk factors for angiodysplasias of the upper and lower gastrointestinal tract: A large population-based study

Gastric Antral Vascular Ectasia (GAVE) a case report, review of the literature and update of techniques

Jejunal angiodysplasia: surgery can be life-saving - a case report

Recurrent gastric antral vascular ectasia: a single center experience

Clinical Application of DSA Disgnosis and Interventional Therapy in Gastrointestinal Hemorrhage

Contrast-enhanced computed tomography assisted diagnosis of bleeding caused by colonic angiodysplasia: A case report

Endoscopic treatment for gastric antral vascular ectasia

Angiographic Diagnosis and Interventional Therapy of Severe Gastrointestinal Bleeding

Angiogenic and anti-angiogenic therapy for gastrointestinal ulcers: new challenges for rational therapeutic predictions and drug design

Gastric Antral Vascular Ectasia: the Evolution of Therapeutic Modalities